New Year Bumper Sale @ Rs. 1 X
Rabicure (Cure Quick) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Acidity. Secondary and off-label uses of Rabicure (Cure Quick) have also been mentioned below.
The correct dosage of Rabicure (Cure Quick) depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Rabicure (Cure Quick) are Diarrhoea. While these are the most often observed Rabicure (Cure Quick) side effects, there are can be others also. These have been listed below. Such side effects of Rabicure (Cure Quick) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Rabicure (Cure Quick)'s effect during pregnancy is Safe and Moderate while nursing. In addition, Rabicure (Cure Quick)'s effects on the liver, heart and kidney are discussed below in the Rabicure (Cure Quick) related warnings section.
Individuals suffering from medical conditions like Diarrhea (Loose Motions) must refrain from the use of Rabicure (Cure Quick) since this can cause severe adverse effects. The section on Rabicure (Cure Quick) contraindications lists all such conditions.
Drug interactions for Rabicure (Cure Quick) have been reported in the medical literature. See below for a complete list.
You should also be aware that Rabicure (Cure Quick) is not safe while driving, and is not addiction.
Rabicure (Cure Quick) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Rabicure (Cure Quick) safe for pregnant women?
Pregnant women can take Rabicure (Cure Quick) safely.
Is the use of Rabicure (Cure Quick) safe during breastfeeding?
Rabicure (Cure Quick) can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Rabicure (Cure Quick) on the Kidneys?
Rabicure (Cure Quick) is not harmful for kidneys.
What is the effect of Rabicure (Cure Quick) on the Liver?
Rabicure (Cure Quick) is rarely harmful for the liver.
What is the effect of Rabicure (Cure Quick) on the Heart?
Using Rabicure (Cure Quick) does not have any harmful effects on the heart.
Rabicure (Cure Quick) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rabicure (Cure Quick) unless your doctor advises you to do so -
Is this Rabicure (Cure Quick) habit forming or addictive?
Forming a habit of Rabicure (Cure Quick) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Rabicure (Cure Quick) as you may feel sleepy.
Is it safe?
There are no side effects of Rabicure (Cure Quick), so it is safe for use.
Is it able to treat mental disorders?
No, the use of Rabicure (Cure Quick) in mental disorders is not effective.
Interaction between Food and Rabicure (Cure Quick)
You can take Rabicure (Cure Quick) with food.
Interaction between Alcohol and Rabicure (Cure Quick)
Consult your doctor before consuming alcohol while taking Rabicure (Cure Quick) as it can have severe side effects.
Yes, Rabicure (Cure Quick) might lead to low magnesium levels in persons who take it for at least 3 months. Magnesium helps in absorption of vitamin D and calcium, low level of magnesium will affect the absorption of Vit. D and calcium lead to decrease bone density and increases the risk of bone fracture. Low-level magnesium can be managed by taking a dietary supplement which is rich in magnesium.
This is because a long-term use of Rabicure (Cure Quick) can cause Vitamin B12 deficiency. Stomach acids help in the absorption of Vitamin B 12, and this drug suppresses stomach acid which is required for the absorption of vitamin B12. Hence patients taking [medicine] for a long time have Vitamin B12 deficiency. To replenish Vitamin B12 in your body your doctor prescribes this vitamin along with this medicine.
Yes, Rabicure (Cure Quick) use is associated with the development of diarrhea. This might be related to an infection caused by Clostridium difficile. If you experience severe diarrhea after consuming this medicine, inform the doctor right away without further delay. In addition, one must take a lot of electrolytes and fluids for preventing dehydration. Taking an anti-diarrheal medication may also help.
Rarely Rabicure (Cure Quick) causes stomach cancer. There has been no direct relationship to establish the fact. However, stomach cancer and other cancers may develop because of recurring acid reflux for a long time for example 7 - 8 years or more. If you feel any symptoms associated with cancer such as consistent low-grade fever, weight loss due to unexplained reasons, and pain in the abdomen, do not hesitate to get it diagnosed by a physician.
Yes, Rabicure (Cure Quick) is given in combination with itopride. The combination is used for the management of gastro-esophageal reflux disorder (GERD).
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Aciphex® (rabeprazole sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 653
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1077-1078